Trastuzumab-Peptide interactions: mechanism and application in structure-based ligand design

Area of Science:

• Biochemistry
• Computational Biology
• Drug Design

Background:

• Protein-ligand interactions are vital for biological processes and drug development.
• Trastuzumab targets HER2-positive breast cancer, but designing stable affinity ligands remains challenging.

Purpose of the Study:

• To computationally analyze binding interactions between trastuzumab and its receptor, HER2.
• To rationally design a stable and high-affinity peptide ligand for HER2.

Main Methods:

• Molecular dynamics (MD) simulations were used to analyze the HER2-trastuzumab complex structure.
• Quantum mechanics and Prime/MM-GBSA calculations predicted binding affinities of designed ligands.

Main Results:

• Trastuzumab binds HER2 via electrostatic and hydrophobic interactions, with electrostatics being dominant.
• A novel peptide ligand was designed with high binding affinity and specificity, comparable to the wild-type.

Conclusions:

• Computational approaches provide valuable insights for designing stable and effective affinity ligands.
• The designed peptide ligand shows promise for HER2-targeted therapies and bio-drug purification.